Johnson Midwest Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Johnson Midwest Financial’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.04K	Hold	200	–	–	﹤0.01%	312
2023 Q2	$1.51K	Hold	200	–	–	﹤0.01%	330
2023 Q1	$1.77K	Hold	200	–	–	﹤0.01%	334
2022 Q4	$2K	Hold	200	–	–	0.01%	334
2022 Q3	$2	Hold	200	–	–	0.01%	305
2022 Q2	$2K	Hold	200	–	–	﹤0.01%	279
2022 Q1	$2K	Hold	200	–	–	﹤0.01%	252
2021 Q4	$2K	Hold	200	–	–	﹤0.01%	270
2021 Q3	$2K	Hold	200	–	–	﹤0.01%	278
2021 Q2	$2K	Hold	200	–	–	﹤0.01%	265
2021 Q1	$2K	Hold	200	–	–	﹤0.01%	245
2020 Q4	$2K	Buy	+200	New	+$1.92K	﹤0.01%	247

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Johnson Midwest Financial's TEVA Position: Q3 2023 in Review

Johnson Midwest Financial held its Teva Pharmaceuticals (TEVA) position steady in Q3 2023 at 200 shares worth $2.04K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

Johnson Midwest Financial first reported a position in TEVA in Q4 2020 and has held it in 12 quarters since. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

Johnson Midwest Financial held 200 shares of Teva Pharmaceuticals worth $2.04K as of Q3 2023.
Johnson Midwest Financial left its Teva Pharmaceuticals share count unchanged in Q3 2023.
Teva Pharmaceuticals made up ﹤0.01% of Johnson Midwest Financial's portfolio in Q3 2023, its #312 holding.
Johnson Midwest Financial first reported a position in Teva Pharmaceuticals in Q4 2020 and has held it in 12 quarters since.
435 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.